Niquitin (Nicotine)

Nicotine, the active ingredient in Niquitin, is a nicotinic agonist presented as an oromucosal formulation for oral mucosal use. It helps adults who want to quit smoking by reducing withdrawal symptoms and cravings. GNH USA supplies Niquitin as a licensed, GDP‑compliant international pharmaceutical supplier serving pharmacies and clinics worldwide.

Niquitin is a nicotine replacement therapy that targets tobacco dependence and supports cessation efforts. - Smoking cessation: reduces cravings and withdrawal symptoms to aid quitting. - Tobacco dependence: provides controlled nicotine to lessen dependence. - Relapse prevention: helps maintain abstinence after quitting.

Common Side Effects: - Mouth irritation or soreness: mild discomfort at the site of administration. - Nausea: transient feeling of queasiness. - Hiccups: brief involuntary diaphragm contractions. - Headache: mild to moderate tension. - Dizziness: temporary light‑headedness. - Altered taste: metallic or bitter sensation.

Serious or Rare Side Effects: - Elevated blood pressure: significant increase requiring medical attention. - Cardiac arrhythmia: irregular heartbeat that may be serious. - Severe allergic reaction: rash, swelling, or breathing difficulty. - Mouth ulceration: deep sores that persist. - Persistent vomiting: uncontrolled emesis needing evaluation.

Before using Niquitin, consider the following precautions. - Assess cardiovascular status: evaluate blood pressure and heart disease history. - Avoid recent myocardial infarction: contraindicated in the immediate post‑event period. - Monitor hypertension: do not use in uncontrolled high blood pressure. - Pregnancy safety: unknown; consult a healthcare professional before use. - Combine with other nicotine sources: avoid using multiple nicotine products simultaneously. - Store at room temperature: keep in the original pack, protect from moisture and heat.

Nicotine can interact with several drug classes, requiring attention to potential effects. Major Interactions (Avoid): - Monoamine oxidase inhibitors (MAOIs): may amplify hypertensive response. - CYP2A6 inhibitors: can increase nicotine plasma levels. - Other nicotine replacement products: risk of nicotine overdose. Moderate Interactions (Monitor Closely): - Selective serotonin reuptake inhibitors (SSRIs): may enhance dizziness. - Antihypertensive agents: nicotine may reduce their efficacy. - Alcohol: may increase nausea and dizziness.